Tags
- Pharmaceuticals
- Biotechnology Company
Description
KemPharm is a development stage biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. The company’s primary efforts include the development of safer, abuse resistant opioid pain relievers. The company’s drug discovery and development platform is based on its proprietary Ligand Activated Therapy (LAT™) approach. KemPharm uses its patent-applied technology to improve existing drugs and shorten the development timeline while still maintaining a strong intellectual property position within each therapeutic area.
